Research and Markets (http://www.researchandmarkets.com/research/8c11de/influenza_vaccines)
has announced the addition of GlobalData 's new report "Influenza
Vaccines - Pipeline Analysis and Market Forecasts to 2016" to their
offering.
“Influenza
Vaccines - Pipeline Analysis and Market Forecasts to 2015”
Influenza
Vaccines - Pipeline Analysis and Market Forecasts to 2016
GlobalData, the industry analysis specialist's new report, "Influenza
Vaccines - Pipeline Analysis and Market Forecasts to 2015", is an
essential source of information and analysis on the global influenza
vaccines market. Key trends shaping and driving the global influenza
vaccines market are clearly identified in the report. The report
provides an insight into the prevalent competitive landscape and the
emerging players expected to bring about a significant shift in the
market positioning of the existing market leaders. Most importantly,
valuable insights into the pipeline products within the global Influenza
vaccines sector are also provided.
Influenza Vaccines Market is forecast to Show High Growth till 2016
GlobalData estimates the global Influenza vaccines market to be worth
$2.8 billion in 2009. It is forecast to grow at a CAGR of 12.7% to reach
$6.4 billion by 2016. This high growth forecast is primarily attributed
to the increase in patient population, a result of increasing world
population, and the need to get vaccinated each year. This growth will
be further supported by increased production capacities of companies to
cater to the rising demand. The strong product pipeline will complement
the existing products by providing effective options to the people.
Current Vaccination Options are Highly Successful in Meeting Market
Demands
GlobalData found that the products currently in the market are highly
efficacious in providing protection against the disease with minimum
side-effects. All the marketed products provide high seroprotection
rates and seroconversion rates against the disease. The key products
like Fluzone, Fluvirin, Fluarix, FluLaval etc. are able to satisfy the
demands of the influenza vaccines market. The unmet need arises from the
fact that vaccination against one strain of virus may not provide
protection against other strains of the influenza virus. More
importantly, the virus strains tend to change every year, and hence
people would have to get vaccinated for protection against the new virus
each year.
Strategic Competitor Assessment of the Influenza Vaccines Market,
January 2010
Unmet Need in the Influenza Vaccines Market is Very Low, Mostly
Characterized by Niche Segments